Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Biocompatibility of glycerol monooleate nanoparticles as tested on inner ear cells
University of Padua, Italy.
Ear Science Institute Australia, Australia; University of Western Australia, Australia.
RISE - Research Institutes of Sweden (2017-2019), Biovetenskap och material, Yta, process och formulering.ORCID-id: 0000-0003-4742-1702
RISE - Research Institutes of Sweden (2017-2019), Biovetenskap och material, Yta, process och formulering.ORCID-id: 0000-0001-8971-3397
Vise andre og tillknytning
2019 (engelsk)Inngår i: International Journal of Pharmaceutics, ISSN 0378-5173, E-ISSN 1873-3476, Vol. 572, artikkel-id 118788Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Sensorineural hearing loss due to aging, noise exposure, trauma or drug ototoxicity is irreversible because cochlear hair cells and neurons cannot regenerate. Recently, therapeutic strategies involving nanoparticles have been developed as innovative drug delivery systems. Thermodynamically stable liquid crystalline nanoparticles based on the polar lipid glycerol monooleate (GMO NP, cubosomes), nontoxic and able to encapsulate both hydrophilic and hydrophobic compounds, were produced and tested for biocompatibility in an immortalized Organ of Corti derived cell line (OC-k3), through cell viability and cytomorphological assays, and Western blot expression profiles of apoptotic markers. Overall, the GMO NP were biocompatible in OC-k3 at the doses and time tested, supporting previous data obtained in a neuronal cell line (PC12). The results encourage further tests on GMO NP-mediated drug release with improved target specificity and could be useful to develop innovative therapies against sensorineural hearing loss.

sted, utgiver, år, opplag, sider
Elsevier B.V. , 2019. Vol. 572, artikkel-id 118788
Emneord [en]
Apoptosis, Cell cycle, Cubosome, OC-k3 cells, Toxicity
HSV kategori
Identifikatorer
URN: urn:nbn:se:ri:diva-40932DOI: 10.1016/j.ijpharm.2019.118788Scopus ID: 2-s2.0-85075399346OAI: oai:DiVA.org:ri-40932DiVA, id: diva2:1376728
Merknad

Funding details: Prat-CPDA110048; Funding details: Ministero dell’Istruzione, dell’Università e della Ricerca, MIUR, PRIN-2010S58B38_004; Funding text 1: This work was supported by the Italian Ministry of Education, University and Research (MIUR) , Italy [grant n. PRIN-2010S58B38_004 ] and the University of Padua (grant n. Prat-CPDA110048 ).

Tilgjengelig fra: 2019-12-10 Laget: 2019-12-10 Sist oppdatert: 2020-06-04bibliografisk kontrollert

Open Access i DiVA

Fulltekst mangler i DiVA

Andre lenker

Forlagets fulltekstScopus

Person

Boge, LukasEriksson, Mimmi

Søk i DiVA

Av forfatter/redaktør
Boge, LukasEriksson, Mimmi
Av organisasjonen
I samme tidsskrift
International Journal of Pharmaceutics

Søk utenfor DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric

doi
urn-nbn
Totalt: 38 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
v. 2.43.0